SSG received the M&A Advisor’s Healthcare/Life Sciences Deal of the Year ($25MM-$50MM) for their role in the Sale of Retrotope, Inc. at the 22nd Annual M&A Advisor Awards ceremony during the 2023 Future of Dealmaking Summit in New York. The 22nd Annual M&A Advisor Awards Gala honored the professionals whose activities set an extremely high standard for dealmaking. For a complete list of winners, visit  22nd M&A Advisor Award Winners.